Glucose Sterile Concentrate B. Braun Medical

Glucose Sterile Concentrate B. Braun Medical is a sterile aqueous solution containing anhydrous glucose as the sole active ingredient. It is supplied as an intravenous (IV) solution without a specified concentration, intended for parenteral administration in clinical settings. The product is classified as an excipient/carbohydrate solution and is marketed in the European Union for use under prescription. It supports energy metabolism during intravenous therapy in hospitalized patients.

Glucose Sterile Concentrate is indicated for several clinical situations where rapid intravenous glucose delivery is required.

- Carbohydrate source in total or supplemental parenteral nutrition formulations. - Treatment of documented hypoglycemia when oral glucose is not feasible. - Component of fluid and electrolyte replacement solutions that provide caloric support. - Maintenance of blood glucose levels during intraoperative or postoperative care. - Dilution medium for certain intravenous medications that require a glucose carrier.

When administered intravenously, glucose solutions may be associated with predictable physiological responses and, rarely, more serious complications.

Common: - Transient hyperglycemia. - Local irritation at the infusion site. - Mild electrolyte shifts, such as changes in sodium or potassium levels.

Serious: - Severe hyperglycemia leading to osmotic diuresis. - Hypoglycemia after abrupt discontinuation of the infusion. - Fluid overload or pulmonary edema in patients with compromised cardiac or renal function. - Allergic or anaphylactic reaction to the solution components.

Clinicians should evaluate patient-specific factors and monitor parameters to minimize risks associated with intravenous glucose administration.

- Assess baseline blood glucose and adjust infusion rate accordingly. - Monitor for signs of fluid overload, especially in patients with cardiac or renal impairment. - Use caution in patients with uncontrolled diabetes mellitus or insulin resistance. - Verify compatibility with other IV drugs before co‑administration. - Avoid rapid infusion rates that exceed recommended osmolarity limits. - Consider electrolyte status, particularly potassium and phosphate, before initiating therapy.

Glucose Sterile Concentrate can interact with other intravenous agents, affecting stability or metabolic outcomes.

Avoid: - Co‑administration with high‑dose insulin infusions without appropriate glucose monitoring. - Mixing with calcium‑containing solutions that may precipitate. - Concurrent use of drugs that cause hyperglycemia (e.g., corticosteroids) without dose adjustment.

Use with caution: - Concurrent administration of potassium chloride solutions, as glucose can drive potassium into cells. - Use alongside diuretics that alter fluid balance, requiring close monitoring. - Combination with other carbohydrate‑containing fluids, which may increase total caloric load.